Uche Ebele, Akinbami Akinsegun, John-Olabode Sarah, Dosunmu Adedoyin, Odesanya Majeed
Department of Haematology and Blood Transfusion, Lagos State University College of Medicine, Ikeja, Nigeria.
Department of Haematology and Blood Transfusion, College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.
Case Rep Med. 2015;2015:648069. doi: 10.1155/2015/648069. Epub 2015 Nov 15.
Multiple myeloma (MM) is a plasma cell disorder associated with clonal proliferation of plasma cells. Nonsecretory multiple myeloma (NSMM) is a rare variant of MM and accounts for approximately 1% to 5% of all cases. It is defined as symptomatic myeloma without detectable monoclonal immunoglobulin on serum or urine electrophoresis. This variant usually poses a diagnostic challenge to the clinician. We present a 60-year-old Nigerian man who was investigated extensively for bone pain, weight loss, and anaemia. He was eventually diagnosed as having nonsecretory multiple myeloma based on histology and immunohistochemistry results of bone marrow trephine biopsy. He is currently being managed with bortezomib, doxorubicin, and thalidomide, as well as zoledronic acid. He is also on anticoagulation. He continues to show remarkable clinical improvement. We describe this case report and literature review for better awareness amongst medical practitioners and pathologists.
多发性骨髓瘤(MM)是一种与浆细胞克隆性增殖相关的浆细胞疾病。非分泌型多发性骨髓瘤(NSMM)是MM的一种罕见变异型,约占所有病例的1%至5%。它被定义为血清或尿电泳检测不到单克隆免疫球蛋白的有症状骨髓瘤。这种变异型通常给临床医生带来诊断挑战。我们报告一名60岁的尼日利亚男性,他因骨痛、体重减轻和贫血接受了广泛检查。最终根据骨髓活检组织学和免疫组化结果诊断为非分泌型多发性骨髓瘤。他目前正在接受硼替佐米、阿霉素和沙利度胺以及唑来膦酸治疗。他也在接受抗凝治疗。他持续表现出显著的临床改善。我们描述该病例报告并进行文献综述,以提高医学从业者和病理学家的认识。